1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Plans
UnitedHealth Group Inc

UnitedHealth Group Inc

UNH.NE
UnitedHealth Group IncCN flagCBOE CA
19.62
CAD
+0.52
- -
509.76BMarket Cap
UnitedHealth Group Inc
UNH.NE
(CBOE CA)

Recent

price

19.62

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.02
3.42
3.78
4.32
4.77
5.75
6.77
7.24
8.22
8.91
9.48
10.63
12.1
14.02
15.25
17.23
17.3
Revenue per Share
0.15
0.17
0.19
0.2
0.21
0.21
0.26
0.38
0.44
0.51
0.57
0.64
0.75
0.84
0.55
0.46
0.46
Basic EPS, GAAP
0.17
0.2
0.21
0.2
0.24
0.3
0.3
0.42
0.5
0.6
0.74
0.74
0.87
0.97
0.79
0.62
0.76
Free Cash Flow per Basic Share
0.01
0.02
0.03
0.04
0.05
0.07
0.08
0.1
0.12
0.14
0.17
0.2
0.22
0.26
0.29
0.3
0.31
Dividend per Share
0.82
0.93
1.05
1.17
1.24
1.36
1.5
1.75
2.03
2.25
2.55
2.85
3.22
3.61
3.66
3.68
3.84
Book Value per Share
0.01
0.05
-0.09
-0.07
-0.1
-0.64
-0.58
-0.4
-0.44
-0.51
-0.43
-0.35
-0.8
-0.75
-1.04
-1.13
-0.97
Tangible Book Value per Share
31,149
29,801
29,228
28,338
27,363
27,335
27,306
27,793
27,535
27,191
27,134
27,048
26,790
26,503
26,245
25,982
25,988
Basic Weighted Avg Shares
94,155
101,862
110,618
122,489
130,474
157,107
184,840
201,159
226,247
242,155
257,141
287,597
324,162
371,622
400,278
447,567
449,713
Sales/Revenue/Turnover
8.35
8.31
8.37
7.86
7.87
7.01
7
7.56
7.67
8.13
8.71
8.33
8.77
8.71
8.07
4.24
4.19
Operating Margin (%)
1,064
1,124
1,309
1,375
1,478
1,693
2,055
2,245
2,428
2,720
2,891
3,103
3,400
3,972
4,099
4,361
4,329
Depreciation Expense
4,634
5,142
5,526
5,625
5,619
5,813
7,017
10,558
11,986
13,839
15,403
17,285
20,120
22,381
14,405
12,056
12,044
Net Income, GAAP
37.23
35.39
35.91
36.37
41.81
42.64
40.38
22.82
22.34
20.81
23.98
20.52
21.65
20.5
24.06
12.86
11.96
Effective Tax Rate (%)
4.92
5.05
5
4.59
4.31
3.7
3.8
5.25
5.3
5.71
5.99
6.01
6.21
6.02
3.6
2.69
2.68
Profit Margin (%)
-5,307
-3,572
-6,064
-7,501
-7,067
-11,259
-15,373
-13,379
-14,517
-19,148
-18,702
-16,534
-20,168
-20,617
-17,990
-24,315
-22,997
Working Capital
11,023
10,656
14,041
14,891
16,007
25,331
25,777
28,835
34,581
36,808
38,648
42,383
54,513
58,263
72,359
72,320
71,440
LT Debt
25,825
28,292
33,299
33,324
33,842
35,461
40,189
52,022
56,227
62,162
70,539
76,479
86,347
98,919
102,591
101,698
105,319
Total Equity
12.92
13.83
13.24
12.27
11.84
10.71
11.03
15.08
15.38
16.04
15.82
16.25
16.84
16.95
14.47
9.25
8.97
Return on Invested Capital (%)
13
13.92
13.33
11.98
11.53
10.07
10.37
13.97
13.96
14.54
14.54
14.78
15.16
15.08
9.41
8.12
7.88
Return on Capital (%)
18.94
19.26
18.89
17.65
16.8
16.38
17.97
23.54
22.92
23.65
23.61
23.61
24.64
24.6
15.02
12.58
12.18
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
7,737
6,069
6,477
LT Borrowings
72,399
72,320
71,440
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
906
906
908
Market Capitalization
302,301
290,674
232,979

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
95,067
90,582
91,127
Cash, Cash Equivalents & STI
30,614
28,121
31,229
Accounts Receivable, Net
22,672
23,018
26,587
Inventories
- -
- -
- -
Total Current Liabilities
115,526
114,897
114,124
Payables & Accruals
76,214
77,369
78,290
ST Debt
7,737
6,069
6,477
Deferred Revenue
3,366
3,413
3,419

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
11.36%
7.74%
-0.87%
Free Cash Flow
8.72%
-3.1%
-22.36%
Net Income, GAAP
9.94%
-2.42%
-16.31%
Sales/Revenue/Turnover
11.09%
11.74%
11.81%
Total Cash Common Dividend
16.2%
11.6%
5.08%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
99,796
98,855
100,820
100,807
400,278
2025
109,575
111,616
113,161
113,215
447,567
2026
111,721
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.05
0.16
0.23
0.21
0.55
2025
0.24
0.13
0.09
- -
0.46
2026
0.24
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.07
0.07
0.07
0.07
0.29
2025
0.07
0.08
0.08
0.08
0.3
2026
0.08
- -
- -
- -
- -
Similar Companies
CVS Health Corporation (0HRS.L)
Humana Inc. (HUM)
Basel Medical Group Ltd Ordinary Shares (BMGL)
OdontoPrev S.A. (ODPV3.SA)
Magellan Health, Inc. (MGLN)
Bright Health Group, Inc. (BHG)
Business
UnitedHealth Group Incorporated (NYSE: UNH) operates as a diversified health care company, providing health benefits through UnitedHealthcare and health services through Optum. UnitedHealthcare offers a broad range of health insurance plans including employer-sponsored benefits, individual and family coverage, Medicare Advantage, Medicaid managed care, and military and veterans' health programs; Optum delivers pharmacy care services via Optum Rx encompassing retail network contracting, home delivery, specialty pharmacy, infusion services, formulary management, drug adherence programs, and step therapy; Optum Health provides primary care, surgical care, urgent care, and value-based care models; Optum Insight focuses on technology solutions, data analytics, consulting, and AI-driven clinical decision support for health systems and providers. The company serves over 150 million individuals domestically and internationally across employer, individual, senior, and government markets, with major operations in the United States and select global regions. Founded in 1974 as Charter Med Incorporated and headquartered in Minnetonka, Minnesota, UnitedHealth Group employs approximately 400,000 people and maintains subsidiaries including Optum Rx, Optum Health, and Optum Insight. Recent developments include the August 2025 completion of the Amedisys home health acquisition, expansion of Optum Rx's limited distribution drug network for rare diseases in November 2025, elimination of reauthorization requirements for over 180 chronic condition drugs by July 2025 with full prior authorization automation via Optum Rx PreCheck, a $4.5 million three-year partnership with Goodwill Industries announced in August 2024 to enhance workforce training in 25 states, and UnitedHealthcare's extension of Individual & Family Marketplace plans to 30 states in November 2024 alongside 2025 Medicare Advantage plan launches emphasizing choice and stability.